6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
8m ago	Trimble Links SketchUp with Anthropic's Claude, Bringing New Conversational AI-powered Capabilities to 3D Modeling
8m ago	Borealis Foods Announces $17.0 Million Refinancing Transaction with Oxus Capital to Repay Frontwell Facility and Support Operations
8m ago	FirstCash Announces Upsize and Pricing of $750 Million Senior Notes Due 2034
8m ago	Vanda Pharmaceuticals announces the publication of "Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis" in NEJM Evidence
9m ago	/C O R R E C T I O N -- Elanco Animal Health/

About

Dermata Therapeutics Inc (NASDAQ:DRMA) — investor relations, events, news, and company updates on 6ix.

Latest News

Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025

Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing

Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office

Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Financials

Revenue

$0

Market Cap

$5.19 M

EPS

-8.16

Community Chat

Ask AI